Sorrento Therapeutics, Inc.
SRNE
SRNE was delisted on the 22nd of February, 2023.
75 hedge funds and large institutions have $235M invested in Sorrento Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 18 closing their positions.
111% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 18
109% more call options, than puts
Call options by funds: $1.31M | Put options by funds: $629K
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
90% more capital invested
Capital invested by funds: $124M → $235M (+$112M)
34% more funds holding
Funds holding: 56 → 75 (+19)
17% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM
Wildcat Capital Management
New York
|
+$9.46M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.79M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$4.36M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$3.76M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$4.9M |
| 2 |
Millennium Management
New York
|
-$4.36M |
| 3 |
TC
Talkot Capital
Sausalito,
California
|
-$1.68M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.65M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.13M |
SRNE Hedge Fund Activity: Q2 2015 in Review
75 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q2 2015, worth a combined $235M — up 90% from $124M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new SRNE positions and 18 closed out — a net gain of 20 holders — while 15 added to existing stakes and 18 trimmed.
The largest buyer was Wildcat Capital Management, opening a new position worth an estimated $9.46M. The largest seller was Numeric Investors, cutting an estimated $4.9M.
- 75 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q2 2015, up from 56 in Q1 2015.
- Funds reported $235M of Sorrento Therapeutics, Inc. stock for Q2 2015, up 90% quarter-over-quarter.
- 38 funds opened new Sorrento Therapeutics, Inc. positions in Q2 2015 and 18 closed out, a net change of +20 holders.
- The largest Sorrento Therapeutics, Inc. buyer in Q2 2015 was Wildcat Capital Management, an estimated $9.46M added.
- The largest Sorrento Therapeutics, Inc. seller in Q2 2015 was Numeric Investors, an estimated $4.9M sold.
Based on aggregated 13F filings for Q2 2015.